Sébastien Lemieux takes over as Scientific Director of Calcul Québec
Sébastien Lemieux, Director of IRIC’s Functional and Structural Bioinformatics Research Unit, was appointed Scientific Director of Calcul Québec last November.
IRIC, located in the heart of the Université de Montréal campus, operates according to a unique model in Canada that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. These generate discoveries that advance knowledge or that can quickly translate into new therapeutic solutions.
Sébastien Lemieux, Director of IRIC’s Functional and Structural Bioinformatics Research Unit, was appointed Scientific Director of Calcul Québec last November.
The team led by Brian Wilhelm, Director of IRIC’s High-Throughput Genomics Research Unit, has developed a new drug discovery platform for high-risk leukemias. Doctoral student Safia Safa-Tahar-Henni led the project, which has been published in the journal Leukemia.
Madline Sauvage, a doctoral student in the laboratories of Delphine Bouilly and Sylvie Mader at IRIC, has been awarded a $6,000 bursary from the Recherche ton Impact entrepreneurial training of the Université de Montréal’s Millénium Québécor program.
Thanks to a major grant of nearly $1.5 million from the Quebec government, CQDM and Epitopea are able to fund a high-potential collaborative research project at the heart of the Université de Montréal, directly involving the research teams of Claude Perreault and Pierre Thibault, principal investigators at IRIC. The aim of the project is to develop a new immunotherapy to effectively treat patients with lung and ovarian cancers.
The John R. Evans Leaders Fund, the Canada Foundation for Innovation and the research support program of Quebec’s ministère de l’Économie, de l’Innovation et de l’Énergie have awarded Dr. Vincent Quoc-Huy Trinh’s lab significant funding for its promising research project: “The effect of fibroblasts on the malignant transformation of dysplastic stem cells in pancreatic tumors”, for the period 2024-2026.
As part of TRANSCAN-3’s joint transnational call 2023 for translational research on cancer epigenetics, Julie Lessard has been awarded a $2,03M grant for the multinational consortium she leads, alongside 5 colleagues from France, Spain and Israel.
To meet the major challenges of our time, the Université de Montréal is launching the “L’heure est brave” campaign. By contributing, you will help the University to develop the potential of its students, innovate for the common good, look after the health of living beings and improve the daily lives of communities. Your donations can make a difference. Let’s join forces to build tomorrow’s world.
Since 2014, IRIC has organized the Audace fundraising event, which contributes annually to funding groundbreaking discoveries in the fight against cancer.
The Audace Gala is much more than just an evening: it’s a moment of sharing, solidarity and hope. Let’s unite our generous hearts to support therapeutic advances through cancer research.
Sokolina K, Kittanakom S, Snider J, Kotlyar M, Maurice P, Gandía J, Benleulmi-Chaachoua A, Tadagaki K, Oishi A, Wong V, Malty RH, Deineko V, Aoki H, Amin S, Yao Z, Morató X, Otasek D, Kobayashi H, Menendez J, Auerbach D, Angers S, Pržulj N, Bouvier M, Babu M, Ciruela F, Jockers R, Jurisica I, Stagljar I
Mol Syst Biol
2025-01-06
;